Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy
Recruiting
Observational Study
Refractory Epilepsy in Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Guangzhou Women and Children's Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the effectiveness of Magnetoencephalography (MEG) in the preoperative assessment of children with refractory epilepsy, particularly in identifying the seizure focus, and to compare it with the gold standard methods of Stereo-electroencephalography (SEEG) and Electrocorticography (ECoG).
The main questions this study aims to answer are:
1. How c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age range: 3-18 years old;
2. Clinically diagnosed with refractory epilepsy;
3. Capable of cooperating with magnetoencephalography evaluation and recording.
Exclusion Criteria:
1. Patients with serious comorbidities or neurological or psychiatric disorders that affect magne…
Contacts